Mullinax tested positive for a substance prohibited by the World Anti-Doping Agency and may return Jan. 16, 2027. He cooperated with the PGA Tour and accepted the suspension.
Mullinax said he used medication for a condition diagnosed in college without first receiving approval under the Tour's anti-doping policy. He accepted responsibility and denied seeking a competitive advantage.